We provide you with 20 years of free, institutional-grade data for ZBH stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ZBH. Explore the full financial landscape of ZBH stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$476,713
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Yi Sang | Sale | -1,200 | $103.58 | $124,302 | 2025-09-15 |
Winkler Lori | Sale | -1,500 | $104.15 | $156,225 | 2025-09-10 |
Stellato Paul A | Sale | -402 | $105.6 | $42,451 | 2025-09-02 |
Stellato Paul A | Derivatives Exercise | 1,281 | 2025-09-02 | ||
Winkler Lori | Sale | -1,500 | $102.49 | $153,735 | 2025-08-20 |
VAN ZUILEN WILFRED | Sale | -692 | $92.77 | $64,197 | 2025-07-03 |
VAN ZUILEN WILFRED | Derivatives Exercise | 2,631 | 2025-07-03 | ||
Yi Sang | Sale | -800 | $92.51 | $74,011 | 2025-06-17 |
Yi Sang | Sale | -1,000 | $95 | $95,000 | 2025-06-13 |
Stellato Paul A | Sale | -197 | $92.24 | $18,171 | 2025-06-03 |
Stellato Paul A | Derivatives Exercise | 626 | 2025-06-03 | ||
VAN ZUILEN WILFRED | Sale | -569 | $104.86 | $59,665 | 2025-03-07 |
VAN ZUILEN WILFRED | Derivatives Exercise | 2,162 | 2025-03-07 | ||
Yi Sang | Derivatives Exercise | 2,365 | 2025-03-07 | ||
Tornos Ivan | Sale | -5,679 | $104.86 | $595,500 | 2025-03-07 |
Tornos Ivan | Derivatives Exercise | 10,268 | 2025-03-07 | ||
Upadhyay Suketu | Sale | -2,029 | $104.86 | $212,761 | 2025-03-07 |
Upadhyay Suketu | Derivatives Exercise | 4,560 | 2025-03-07 | ||
Phipps Chad F | Sale | -824 | $104.86 | $86,405 | 2025-03-07 |
Phipps Chad F | Derivatives Exercise | 2,094 | 2025-03-07 | ||
Bezjak Mark | Sale | -638 | $104.86 | $66,901 | 2025-03-07 |
Bezjak Mark | Derivatives Exercise | 1,621 | 2025-03-07 | ||
Winkler Lori | Derivatives Exercise | 1,757 | 2025-03-07 | ||
Winkler Lori | Sale | -2,135 | $104.4 | $222,894 | 2025-03-07 |
Stellato Paul A | Sale | -191 | $104.86 | $20,028 | 2025-03-07 |
Stellato Paul A | Derivatives Exercise | 608 | 2025-03-07 | ||
Winkler Lori | Sale | -465 | $103.46 | $48,109 | 2025-02-24 |
Winkler Lori | Derivatives Exercise | 1,907 | 2025-02-24 | ||
Phipps Chad F | Sale | -885 | $103.46 | $91,562 | 2025-02-24 |
Phipps Chad F | Derivatives Exercise | 2,247 | 2025-02-24 | ||
Ellingson Rachel | Sale | -491 | $103.46 | $50,799 | 2025-02-24 |
Ellingson Rachel | Derivatives Exercise | 1,566 | 2025-02-24 | ||
Stellato Paul A | Sale | -258 | $103.46 | $26,693 | 2025-02-24 |
Stellato Paul A | Derivatives Exercise | 702 | 2025-02-24 | ||
Tornos Ivan | Sale | -8,846 | $103.46 | $915,207 | 2025-02-24 |
Tornos Ivan | Derivatives Exercise | 15,996 | 2025-02-24 | ||
Upadhyay Suketu | Sale | -2,423 | $103.46 | $250,684 | 2025-02-24 |
Upadhyay Suketu | Derivatives Exercise | 5,446 | 2025-02-24 | ||
VAN ZUILEN WILFRED | Sale | -645 | $103.46 | $66,732 | 2025-02-24 |
VAN ZUILEN WILFRED | Derivatives Exercise | 2,451 | 2025-02-24 | ||
Yi Sang | Derivatives Exercise | 2,383 | 2025-02-24 | ||
Bezjak Mark | Sale | -694 | $103.46 | $71,801 | 2025-02-24 |
Bezjak Mark | Derivatives Exercise | 2,519 | 2025-02-24 | ||
Upadhyay Suketu | Sale | -8,155 | $101 | $823,655 | 2025-02-19 |
Upadhyay Suketu | Derivatives Exercise | 21,622 | 2025-02-19 | ||
Bezjak Mark | Sale | -1,954 | $101 | $197,354 | 2025-02-19 |
Bezjak Mark | Derivatives Exercise | 7,865 | 2025-02-19 | ||
Ellingson Rachel | Sale | -1,792 | $101 | $180,992 | 2025-02-19 |
Ellingson Rachel | Derivatives Exercise | 5,572 | 2025-02-19 | ||
Phipps Chad F | Sale | -2,552 | $101 | $257,752 | 2025-02-19 |
Phipps Chad F | Derivatives Exercise | 10,158 | 2025-02-19 | ||
VAN ZUILEN WILFRED | Sale | -2,414 | $101 | $243,814 | 2025-02-19 |
VAN ZUILEN WILFRED | Derivatives Exercise | 9,174 | 2025-02-19 | ||
Yi Sang | Derivatives Exercise | 11,138 | 2025-02-19 | ||
Winkler Lori | Sale | -1,802 | $101 | $182,002 | 2025-02-19 |
Winkler Lori | Derivatives Exercise | 7,208 | 2025-02-19 | ||
Tornos Ivan | Sale | -12,826 | $101 | $1,295,426 | 2025-02-19 |
Tornos Ivan | Derivatives Exercise | 25,878 | 2025-02-19 | ||
Upadhyay Suketu | Sale | -7,097 | $108.48 | $769,883 | 2024-11-12 |
Upadhyay Suketu | Derivatives Exercise | 15,948 | 2024-11-12 | ||
VAN ZUILEN WILFRED | Sale | -557 | $107.36 | $59,800 | 2024-07-03 |
VAN ZUILEN WILFRED | Derivatives Exercise | 2,633 | 2024-07-03 | ||
Yi Sang | Sale | -12,857 | $114.69 | $1,474,582 | 2024-06-04 |
Stellato Paul A | Sale | -197 | $114.47 | $22,551 | 2024-06-04 |
Stellato Paul A | Derivatives Exercise | 627 | 2024-06-04 | ||
Winkler Lori | Sale | -215 | $130.65 | $28,090 | 2024-04-03 |
Winkler Lori | Derivatives Exercise | 772 | 2024-04-03 | ||
Stellato Paul A | Sale | -224 | $125.82 | $28,184 | 2024-03-08 |
Stellato Paul A | Derivatives Exercise | 609 | 2024-03-08 | ||
Ellingson Rachel | Sale | -445 | $125.82 | $55,990 | 2024-03-08 |
Ellingson Rachel | Derivatives Exercise | 1,419 | 2024-03-08 | ||
Phipps Chad F | Sale | -825 | $125.82 | $103,802 | 2024-03-08 |
Phipps Chad F | Derivatives Exercise | 2,095 | 2024-03-08 | ||
Yi Sang | Sale | -1,705 | $126.86 | $216,296 | 2024-03-08 |
Yi Sang | Derivatives Exercise | 4,070 | 2024-03-08 | ||
Bezjak Mark | Sale | -395 | $125.82 | $49,699 | 2024-03-08 |
Bezjak Mark | Derivatives Exercise | 1,622 | 2024-03-08 | ||
Winkler Lori | Sale | -428 | $125.82 | $53,851 | 2024-03-08 |
Winkler Lori | Derivatives Exercise | 1,757 | 2024-03-08 | ||
VAN ZUILEN WILFRED | Sale | -260 | $125.82 | $32,713 | 2024-03-08 |
VAN ZUILEN WILFRED | Derivatives Exercise | 2,163 | 2024-03-08 | ||
Tornos Ivan | Sale | -5,642 | $125.82 | $709,876 | 2024-03-08 |
Tornos Ivan | Derivatives Exercise | 10,270 | 2024-03-08 | ||
Upadhyay Suketu | Sale | -1,919 | $125.82 | $241,449 | 2024-03-08 |
Upadhyay Suketu | Derivatives Exercise | 4,561 | 2024-03-08 |
The information provided in this report about ZBH stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zimmer Biomet Holdings, Inc(NYSE:ZBH)


Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip re...
Website: http://www.zimmerbiomet.in
Founded: 1927
Full Time Employees: 19,900
Sector: Healthcare
Industry: Medical Devices